Lung volume recruitment in patients with Duchenne Muscular Dystrophy in the early non-ambulatory stage

被引:0
|
作者
Alvarez, Wendy [1 ]
Montero, Sebastian [1 ]
Huerta, Antonio [2 ,3 ]
Moraga, Arlette [1 ]
Saavedra, Cristian [1 ]
Solis, Fresia [1 ]
Prado, Francisco [2 ,3 ,4 ]
机构
[1] Inst Teleton Santiago, Santiago, Chile
[2] Hosp Clin San Borja Arriaran, Serv Pediat, Unidad Hospitalizac Domiciliaria NANEAS, Santiago, Chile
[3] Grp Iberoamer Cuidados Resp Enfermedades Neuromusc, Santiago, Chile
[4] Univ Chile, Dept Pediat & Cirugia, Campus Ctr, Santiago, Chile
来源
ANDES PEDIATRICA | 2025年 / 96卷 / 01期
关键词
Duchenne Muscular Dystrophy; Neuromuscular Disease; Vital Capacity; Cough; Respiratory Muscles; Rehabilitation Center; QUALITY-OF-LIFE; VITAL CAPACITY; INSUFFLATION CAPACITY; RESPIRATORY-FUNCTION; AIR STACKING; VENTILATION; DISORDERS; DIAGNOSIS; HEALTHY;
D O I
10.32641/andespediatr.v96i1.5190
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Ventilatory and cough insufficiency are the main causes of morbidity and mortality in patients with Duchenne muscular dystrophy (DMD). Lung volume recruitment (LVR) might decrease the decline in vital capacity (VC). Objective: To determine the changes produced by respiratory training performed at home with LVR techniques and manually assisted cough on VC, maximum insufflation capacity (MIC), and peak cough flow (PCF) in adolescents with DMD in the early non-ambulatory stage. Patients and Method: Quasi-experimental study with repeated measurements every three months. 16 adolescents with DMD close to the CV plateau and cough insufficiency were evaluated and trained daily in LVR and assisted cough, with follow-up for 12 months, assessing respiratory function, quality of life, and caregiver overload. Results: Eleven users (69%), aged 12.7 +/- 2.8 years, completed the follow-up. Supine position VC and PCF + compression increased significantly (p = 0.047; p = 0.012, respectively). Seated VC and MIC tended to improve by 11.2% and 21.6%, respectively. Quality of life and caregiver overload did not present significant changes. Conclusion: In adolescents with DMD in the early non-ambulatory stage, significant improvements were observed in VC and cough capacity. This provides an intervention of easy implementation, capable of preventing the expected respiratory functional decline.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 50 条
  • [21] A Canadian Survey on Lung Volume Recruitment (LVR) in Children with Duchenne Muscular Dystrophy
    Mah, Jean
    McKim, Douglas
    Hoey, Lynda
    Barrowman, Nick
    Katz, Sherri
    NEUROLOGY, 2011, 76 (09) : A108 - A108
  • [22] Lung Volume Recruitment Slows Pulmonary Function Decline in Duchenne Muscular Dystrophy
    McKim, Douglas A.
    Katz, Sherri L.
    Barrowman, Nicholas
    Ni, Andy
    LeBlanc, Carole
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2012, 93 (07): : 1117 - 1122
  • [23] ACTIVE LUNG VOLUME RECRUITMENT TO PRESERVE VITAL CAPACITY IN DUCHENNE MUSCULAR DYSTROPHY
    Chiou, Michael
    Bach, John R.
    Jethani, Lavina
    Gallagher, Michael F.
    JOURNAL OF REHABILITATION MEDICINE, 2017, 49 (01) : 49 - 53
  • [24] Eteplirsen-Treatment Attenuates Respiratory Decline in Ambulatory and Non-ambulatory Patients With Duchenne Muscular Dystrophy: Comparison With Natural History Cohorts
    Khan, Navid
    Han, Lixin
    Kinane, Bernard
    Gordish-Dressman, Heather
    Lowes, Linda
    McDonald, Craig
    NEUROLOGY, 2019, 92 (15)
  • [25] Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy1
    McDonald, Craig M.
    Mayer, Oscar H.
    Hor, Kan N.
    Miller, Debra
    Goemans, Nathalie
    Henricson, Erik K.
    Marden, Jessica R.
    Freimark, Jonathan
    Lane, Henry
    Zhang, Adina
    Frean, Molly
    Trifillis, Panayiota
    Koladicz, Karyn
    Signorovitch, James
    JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (01) : 67 - 79
  • [26] Analysis of upper limb functional outcomes in a single centre paediatric cohort of non-ambulatory patients with Duchenne muscular dystrophy
    Burnett, N.
    Ridout, D.
    Crook, V.
    Robb, S.
    Zambon, A.
    Quinlivan, R.
    Main, M.
    Manzur, A.
    Muntoni, F.
    Sarkozy, A.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S84 - S85
  • [27] Hand grip strength as a predictor of general functional capacity in non-ambulatory children with Duchenne muscular dystrophy
    Bulut, N.
    Alemdaroglu, I.
    Yilmaz, O.
    Topaloglu, H.
    Karaduman, A.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S184 - S184
  • [28] Routine lung volume recruitment in boys with Duchenne muscular dystrophy: a randomised clinical trial
    Katz, Sherri L.
    Mah, Jean K.
    McMillan, Hugh J.
    Campbell, Craig
    Bijelic, Vid
    Barrowman, Nick
    Momoli, Franco
    Blinder, Henrietta
    Aaron, Shawn D.
    McAdam, Laura C.
    Nguyen, The Thanh Diem
    Tarnopolsky, Mark
    Wensley, David F.
    Zielinski, David
    Rose, Louise
    Sheers, Nicole
    Berlowitz, David J.
    Wolfe, Lisa
    McKim, Doug
    THORAX, 2022, 77 (08) : 805 - 811
  • [29] Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy
    Connolly, Anne M.
    Zaidman, Craig M.
    Brandsema, John F.
    Phan, Han C.
    Tian, Cuixia
    Zhang, Xueping
    Li, Jack
    Eisner, Mark D.
    Carrier, Ewa
    JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (04) : 685 - 699
  • [30] Development and evaluation of a composite time-to-progression endpoint that spans ambulatory and non-ambulatory stages of Duchenne muscular dystrophy (DMD)
    McDonald, C.
    Muntoni, F.
    Marden, J.
    Goemans, N.
    Gomez-Lievano, A.
    Zhang, A.
    Chen, Z.
    Ward, S.
    Signorovitch, J.
    NEUROMUSCULAR DISORDERS, 2023, 33 : S82 - S82